This test incorporates serum PSA and two urinary biomarkers (PCA3 and TMPRSS2-ERG) in a logistic regression model that calculates a score for detecting PC and predicting HGPC (Gleason score ≥ 7) on prostate biopsy. Here, PCA3 is linked to pachyonychia congenita.